11β-Hydroxysteroid Dehydrogenase Type 1 in Obese Subjects With Type 2 Diabetes Mellitus

被引:14
作者
Li, Xia [1 ]
Wang, Jingli [2 ]
Yang, Qin [3 ]
Shao, Shiying [4 ]
机构
[1] Three Gorges Univ, Peoples Hosp, Peoples Hosp Yichang 1, Div Endocrinol, Yichang, Peoples R China
[2] Jingzhou Cent Hosp, Div Endocrinol, Jingzhou, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Div Pathol, Jiefang Rd 1095, Wuhan 430030, Hubei, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Hosp, Div Endocrinol, Wuhan, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
11 beta-Hydroxysteroid dehydrogenase type 1; Obesity; Type 2 diabetes mellitus; Insulin resistance; INSULIN-RECEPTOR SUBSTRATE-1; SUBCUTANEOUS ADIPOSE-TISSUE; 11-BETA-HSD1; INHIBITION; SELECTIVE-INHIBITION; CORTISOL METABOLISM; GLUCOSE-TOLERANCE; PANCREATIC-ISLETS; BI; 135585; MICE; RESISTANCE;
D O I
10.1016/j.amjms.2017.03.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity is one of the most significant contributors to the development of type 2 diabetes mellitus. Tissue-specific glucocorticoids regulated by 11 beta-hydroxysteroid dehydrogenase enzyme (11 beta-HSD) type 1 are involved in central obesity and obesity-related comorbidities. Moderate downregulation of 11 beta-HSD1 can attenuate insulin insensitivity and the impairment of glucose-stimulated insulin secretion. Some of the beneficial effects of 11 beta-HSD1 inhibition may be mediated, at least in part, through inactivation of tissue-specific glucocorticoid action related to insulin signaling mechanisms, alleviation of abnormal cytokine profile and the improvement of beta-cell function. Thus, 11 beta-HSD1 is a promising target for the treatment and prevention of type 2 diabetes mellitus with obesity.
引用
收藏
页码:408 / 414
页数:7
相关论文
共 86 条
[1]   Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose [J].
Abdul-Ghani, MA ;
Tripathy, D ;
DeFronzo, RA .
DIABETES CARE, 2006, 29 (05) :1130-1139
[2]   Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver [J].
Abel, ED ;
Peroni, O ;
Kim, JK ;
Kim, YB ;
Boss, O ;
Hadro, E ;
Minnemann, T ;
Shulman, GI ;
Kahn, BB .
NATURE, 2001, 409 (6821) :729-733
[3]   The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307 [J].
Aguirre, V ;
Uchida, T ;
Yenush, L ;
Davis, R ;
White, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :9047-9054
[4]   Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains [J].
Alberts, P ;
Nilsson, C ;
Selén, G ;
Engblom, LOM ;
Edling, NHM ;
Norling, S ;
Klingström, G ;
Larsson, C ;
Forsgren, M ;
Ashkzari, M ;
Nilsson, CE ;
Fiedler, M ;
Bergqvist, E ;
Öhman, B ;
Björkstrand, E ;
Abrahmsén, LB .
ENDOCRINOLOGY, 2003, 144 (11) :4755-4762
[5]   Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice [J].
Alberts, P ;
Engblom, L ;
Edling, N ;
Forsgren, M ;
Klingström, G ;
Larsson, C ;
Rönquist-Nii, Y ;
Öhman, B ;
Abrahmsén, L .
DIABETOLOGIA, 2002, 45 (11) :1528-1532
[6]   Diagnosis and complications of Cushing's syndrome: A consensus statement [J].
Arnaldi, G ;
Angeli, A ;
Atkinson, AB ;
Bertagna, X ;
Cavagnini, F ;
Chrousos, GP ;
Fava, GA ;
Findling, JW ;
Gaillard, RC ;
Grossman, AB ;
Kola, B ;
Lacroix, A ;
Mancini, T ;
Mantero, F ;
Newell-Price, J ;
Nieman, LK ;
Sonino, N ;
Vance, ML ;
Giustina, A ;
Boscaro, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12) :5593-5602
[7]   Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11β-hydroxysteroid dehydrogenase type 1 [J].
Berthiaume, Magalie ;
Laplante, Mathieu ;
Festuccia, William ;
Gelinas, Yves ;
Poulin, Sebastien ;
Lalonde, Josee ;
Joanisse, Denis R. ;
Thieringer, Rolf ;
Deshaies, Yves .
ENDOCRINOLOGY, 2007, 148 (05) :2391-2397
[8]   Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance? [J].
Blueher, Matthias .
CLINICAL SCIENCE, 2016, 130 (18) :1603-1614
[9]   Pioglitazone in adult rats reverses immediate postnatal overfeeding-induced metabolic, hormonal, and inflammatory alterations [J].
Boullu-Ciocca, S. ;
Tassistro, V. ;
Dutour, A. ;
Grino, M. .
ENDOCRINE, 2015, 50 (03) :608-619
[10]   Does central obesity reflect ''Cushing's disease of the omentum''? [J].
Bujalska, IJ ;
Kumar, S ;
Stewart, PM .
LANCET, 1997, 349 (9060) :1210-1213